Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-17

Clinical Trial Update: Treatment of Children With Insufficient Secretion of Growth Hormone [Phase 3]

View source ↗

Summary

This Phase 3 trial sponsored by LG Life Sciences aims to treat children with growth hormone deficiency, but the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LG Life Sciences growth hormone therapy (investigational)

Snippet

Sponsor: LG Life Sciences | Conditions: Growth Hormone Deficiency (GHD) | Phase 3 | Status: UNKNOWN